{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:24Z","timestamp":1786982244891,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National research fund of Korea","award":["NRF-2019M2D2A1A01031560"],"award-info":[{"award-number":["NRF-2019M2D2A1A01031560"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12072-022-10343-6","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T05:03:52Z","timestamp":1652072632000},"page":"712-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Benefit of adjuvant radiotherapy for gallbladder cancer: a comparability-based meta-analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Seo Hee","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-4588","authenticated-orcid":false,"given":"Chai Hong","family":"Rim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Sup","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woong Sub","family":"Koom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsil","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"10343_CR1","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, Klimstra D, D\u2019Angelica M, DeMatteo RP, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689\u20131700","journal-title":"Cancer"},{"key":"10343_CR2","first-page":"1609","volume":"51","author":"M Aramaki","year":"2004","unstructured":"Aramaki M, Matsumoto T, Shibata K, Himeno Y, Yada K, Hirano S, et al. Factors influencing recurrence after surgical treatment for t2 gallbladder carcinoma. Hepatogastroenterology. 2004;51:1609\u20131611","journal-title":"Hepatogastroenterology"},{"key":"10343_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","volume":"14","author":"WS Kim","year":"2010","unstructured":"Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010;14:679\u2013687","journal-title":"J Gastrointest Surg"},{"key":"10343_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s11605-007-0109-z","volume":"11","author":"JS Park","year":"2007","unstructured":"Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, et al. Actual recurrence patterns and risk factors influencing recurrence after curative resection with stage ii gallbladder carcinoma. J Gastrointest Surg. 2007;11:631\u2013637","journal-title":"J Gastrointest Surg"},{"key":"10343_CR5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase iii multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685\u20131695","journal-title":"Cancer"},{"key":"10343_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","volume":"15","author":"N Ma","year":"2015","unstructured":"Ma N, Cheng H, Qin B, Zhong R, Wang B. Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis. BMC Cancer. 2015;15:615","journal-title":"BMC Cancer"},{"key":"10343_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1245\/s10434-017-6139-1","volume":"25","author":"BH Kim","year":"2018","unstructured":"Kim BH, Kwon J, Chie EK, Kim K, Kim YH, Seo DW, et al. Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25:255\u2013264","journal-title":"Ann Surg Oncol"},{"key":"10343_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181fe7825","volume":"22","author":"D Moher","year":"2011","unstructured":"Moher D, Altman DG, Liberati A, Tetzlaff J. Prisma statement. Epidemiology. 2011;22:128","journal-title":"Epidemiology"},{"key":"10343_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2019","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. New York: Wiley; 2019"},{"key":"10343_CR10","unstructured":"Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, Noel-Storr A, Rader T, Shokraneh F, Thomas J, Wieland LS. Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors) Cochrane handbook for systematic reviews of interventions version 6.2 (updated february 2021). Cochrane, 2021. www.Training.Cochrane.Org\/handbook."},{"key":"10343_CR11","unstructured":"Peterson J, Welch V, Losos M, Tugwell P. The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 2 Apr 2021."},{"key":"10343_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Ch 24.6: synthesis of results from non-randomized studies. Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2019","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Ch 24.6: synthesis of results from non-randomized studies. Cochrane handbook for systematic reviews of interventions. New York: Wiley; 2019"},{"key":"10343_CR13","first-page":"595","volume-title":"Including non-randomized studies on intervention effects. Cochrane handbook for systematic reviews of interventions","author":"BC Reeves","year":"2019","unstructured":"Reeves BC, Deeks JJ, Higgins JP, Shea B, Tugwell P, Wells GA, Cochrane Non-Randomized Studies of Interventions Methods Group. Including non-randomized studies on intervention effects. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester (UK): John Wiley & Sons; 2019. pp. 595\u2013620.","edition":"2"},{"key":"10343_CR14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u20131558","journal-title":"Stat Med"},{"key":"10343_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101\u2013129","journal-title":"Biometrics"},{"key":"10343_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629\u2013634","journal-title":"Br Med J"},{"key":"10343_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u2013463","journal-title":"Biometrics"},{"key":"10343_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.gassur.2005.12.002","volume":"10","author":"P Balachandran","year":"2006","unstructured":"Balachandran P, Agarwal S, Krishnani N, Pandey CM, Kumar A, Sikora SS, et al. Predictors of long-term survival in patients with gallbladder cancer. J Gastrointest Surg. 2006;10:848\u2013854","journal-title":"J Gastrointest Surg"},{"key":"10343_CR19","doi-asserted-by":"publisher","first-page":"S1467","DOI":"10.1016\/S0016-5085(19)40735-X","volume":"156","author":"EY Bekhor","year":"2019","unstructured":"Bekhor EY, Bolton NM, Sullivan B, Solomon D, DeNicola N, Hofstedt M, et al. Mo1417-adjuvant treatment for advanced gallbladder cancer; does external beam radiation therapy play a role? Gastroenterology. 2019;156:S1467","journal-title":"Gastroenterology"},{"key":"10343_CR20","first-page":"XC01","volume":"9","author":"S Choudhary","year":"2015","unstructured":"Choudhary S, Asthana AK. Impact of adjuvant therapy on survival in curatively resected gallbladder carcinoma. J Clin Diagn Res JCDR. 2015;9:XC01","journal-title":"J Clin Diagn Res JCDR"},{"key":"10343_CR21","first-page":"1274","volume":"48","author":"S-I Go","year":"2016","unstructured":"Go S-I, Kim YS, Hwang IG, Kim EY, Oh SY, Ji JH, et al. Is there a role for adjuvant therapy in r0 resected gallbladder cancer? A propensity score-matched analysis. Cancer Res Treat Off J Korean Cancer Assoc. 2016;48:1274","journal-title":"Cancer Res Treat Off J Korean Cancer Assoc"},{"key":"10343_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijrobp.2008.10.052","volume":"75","author":"DG Gold","year":"2009","unstructured":"Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, et al. Adjuvant therapy for gallbladder carcinoma: the mayo clinic experience. Int J Radiat Oncol Biol Phys. 2009;75:150\u2013155","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10343_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijrobp.2017.09.029","volume":"100","author":"B Gu","year":"2018","unstructured":"Gu B, Qian L, Yu H, Hu J, Wang Q, Shan J, et al. Concurrent chemoradiotherapy in curatively resected gallbladder carcinoma: a propensity score\u2013matched analysis. Int J Radiat Oncol Biol Phys. 2018;100:138\u2013145","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10343_CR24","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s10620-005-3040-8","volume":"50","author":"H Itoh","year":"2005","unstructured":"Itoh H, Nishijima K, Kurosaka Y, Takegawa S, Kiriyama M, Dohba S, et al. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci. 2005;50:2231\u20132242","journal-title":"Dig Dis Sci"},{"key":"10343_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/2278-0513.119264","volume":"2","author":"R Kapoor","year":"2013","unstructured":"Kapoor R, Singh PK, Bahl A, Kumar R, Kumar N, Gupta R, et al. Potential for adjuvant treatment after radical resection in carcinoma gallbladder: a tertiary care experience from India. Clin Cancer Investig J. 2013;2:207","journal-title":"Clin Cancer Investig J"},{"key":"10343_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"TH Kim","year":"2019","unstructured":"Kim TH, Woo SM, Lee WJ, Oh ES, Youn SH, Moon SH, et al. Benefit of adjuvant chemoradiotherapy in resected gallbladder carcinoma. Sci Rep. 2019;9:1\u20138","journal-title":"Sci Rep"},{"key":"10343_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","volume":"14","author":"WS Kim","year":"2010","unstructured":"Kim WS, Choi DW, Do You D, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010;14:679\u2013687","journal-title":"J Gastrointest Surg"},{"issue":"3 Suppl","key":"10343_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1200\/jco.2015.33.3_suppl.405","volume":"33","author":"N Kothari","year":"2015","unstructured":"Kothari N, Kim RD, Springett GM, Hoffe SE, Almhanna K, Hodul PJ, Pimiento JM, Malafa MP, Fulp WJ, Zhao X. Surgery and adjuvant therapy in gallbladder cancer: a single-institution experience. J Clin Oncol. 2015;33(3 Suppl):405. https:\/\/doi.org\/10.1200\/jco.2015.33.3_suppl.405.","journal-title":"J Clin Oncol"},{"key":"10343_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4174\/jkss.2012.83.4.227","volume":"83","author":"HY Lee","year":"2012","unstructured":"Lee HY, Kim YH, Jung GJ, Roh YH, Park SY, Kang NU, et al. Prognostic factors for gallbladder cancer in the laparoscopy era. J Korean Surg Soc. 2012;83:227","journal-title":"J Korean Surg Soc"},{"key":"10343_CR30","first-page":"310","volume":"50","author":"G Lindell","year":"2003","unstructured":"Lindell G, Holmin T, Ewers SB, Tranberg K-G, Stenram U, Ihse I. Extended operation with or without intraoperative (iort) and external (ebrt) radiotherapy for gallbladder carcinoma. Hepatogastroenterology. 2003;50:310\u2013314","journal-title":"Hepatogastroenterology"},{"issue":"7","key":"10343_CR31","doi-asserted-by":"publisher","first-page":"djw324","DOI":"10.1093\/jnci\/djw324","volume":"109","author":"T Mitin","year":"2017","unstructured":"Mitin T, Enestvedt CK, Jemal A, Sineshaw HM. Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival. JNCI J Natl Cancer Inst. 2017;109(7):djw324. https:\/\/doi.org\/10.1093\/jnci\/djw324","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10343_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jso.20831","volume":"96","author":"P Mojica","year":"2007","unstructured":"Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol. 2007;96:8\u201313","journal-title":"J Surg Oncol"},{"key":"10343_CR33","first-page":"1806","volume":"50","author":"R Mondragon-Sanchez","year":"2003","unstructured":"Mondragon-Sanchez R, Gonzalez-Geroniz M, Onate-Ocana LF, Garduno-Lopez AL, Mondragon-Sanchez A, Bernal-Maldonado R, et al. A retrospective analysis of patients with gallbladder cancer treated with radical resection versus cholecystectomy plus external radiotherapy. Hepatogastroenterology. 2003;50:1806\u20131810","journal-title":"Hepatogastroenterology"},{"issue":"13 Suppl","key":"10343_CR34","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1158\/1538-7445.AM2017-3283","volume":"77","author":"L Nandagopal","year":"2017","unstructured":"Nandagopal L, Heslin MJ, Porterfield JR, Jacob R, Li P, Posey J, Paluri R. Adjuvant therapy associated with improved survival in gall bladder cancer: a single institution retrospective study. Cancer Res. 2017;77(13 Suppl):3283.","journal-title":"Cancer Res"},{"key":"10343_CR35","first-page":"130","volume":"81","author":"A Okamoto","year":"1996","unstructured":"Okamoto A, Tsuruta K, Ishiwata J, Isawa T, Kamisawa T, Tanaka Y. Treatment of t3 and t4 carcinomas of the gallbladder. Int Surg. 1996;81:130\u2013135","journal-title":"Int Surg"},{"key":"10343_CR36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1365-2168.1999.01085.x","volume":"86","author":"T Todoroki","year":"1999","unstructured":"Todoroki T, Kawamoto T, Takahashi H, Takada Y, Koike N, Otsuka M, et al. Treatment of gallbladder cancer by radical resection. Br J Surg. 1999;86:622\u2013627","journal-title":"Br J Surg"},{"key":"10343_CR37","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1245\/s10434-015-4685-y","volume":"22","author":"J Wang","year":"2015","unstructured":"Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, et al. Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma: a multi-institutional experience. Ann Surg Oncol. 2015;22:1100\u20131106","journal-title":"Ann Surg Oncol"},{"key":"10343_CR38","first-page":"534","volume":"35","author":"L Yang","year":"2013","unstructured":"Yang L, Feng F, Zhou H, Sun Y, Meng Y. Analysis of the efficacy of postoperative radiotherapy in gallbladder cancer. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2013;35:534\u2013539","journal-title":"Zhonghua zhong liu za zhi [Chinese journal of oncology]"},{"issue":"4","key":"10343_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21037\/cco.2019.07.02","volume":"8","author":"E Suzuki","year":"2019","unstructured":"Suzuki E, Bridgewater J. Adjuvant therapy for resected gallbladder cancer. Chin Clin Oncol. 2019;8(4):39. https:\/\/doi.org\/10.21037\/cco.2019.07.02","journal-title":"Chin Clin Oncol"},{"key":"10343_CR40","unstructured":"National cancer comprehensive network. Nccn guidelines ver 2.2021, hepatobiliary cancers. Assessed 27 May 2021."},{"key":"10343_CR41","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative analyses of normal tissue effects in the clinic (quantec): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76:S3\u2013S9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10343_CR42","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.3346\/jkms.2021.36.e117","volume":"36","author":"J Lee","year":"2021","unstructured":"Lee J, Kim WC, Yoon WS, Rim CH. Implications of radiotherapy utilization in Korea from 2010 to 2019. J Korean Med Sci. 2021;36(18):e117.","journal-title":"J Korean Med Sci"},{"key":"10343_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3748\/wjg.v17.i3.397","volume":"17","author":"X-N Sun","year":"2011","unstructured":"Sun X-N, Wang Q, Gu B-X, Zhu Y-H, Hu J-B, Shi G-Z, et al. Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy. World J Gastroenterol WJG. 2011;17:397","journal-title":"World J Gastroenterol WJG"},{"key":"10343_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.radonc.2014.11.043","volume":"114","author":"M-I Bittner","year":"2015","unstructured":"Bittner M-I, Grosu A-L, Brunner TB. Comparison of toxicity after imrt and 3d-conformal radiotherapy for patients with pancreatic cancer\u2014a systematic review. Radiother Oncol. 2015;114:117\u2013121","journal-title":"Radiother Oncol"},{"key":"10343_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/medicina57020117","volume":"57","author":"I-S Shin","year":"2021","unstructured":"Shin I-S, Rim CH. Updating perspectives on meta-analyses in the field of radiation oncology. Medicina. 2021;57:117","journal-title":"Medicina"},{"key":"10343_CR46","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/aje\/kwm189","volume":"166","author":"I Shrier","year":"2007","unstructured":"Shrier I, Boivin J-F, Steele RJ, Platt RW, Furlan A, Kakuma R, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol. 2007;166:1203\u20131209","journal-title":"Am J Epidemiol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10343-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10343-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10343-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T13:14:49Z","timestamp":1675516489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10343-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10343"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10343-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Seo Hee Choi, Chai Hong Rim, In-Soo Shin, Won Sup Yoon, Woong Sub Koom, Jinsil Seong have any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors have completed the PRISMA reporting checklist.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reporting checklist"}},{"value":"This study is registered in PROSPERO (CRD42021240624, available at:\n                      \n                      ).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protocol registration"}},{"value":"Data available within the article or its supplementary materials.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}}]}}